Merck’s challenge to medicare drug pricing could cause ‘narrative shift’ in pharma, says Jared Holz

June 7, 2023
Merck’s challenge to medicare drug pricing could cause ‘narrative shift’ in pharma, says Jared HolzMerck’s challenge to medicare drug pricing could cause ‘narrative shift’ in pharma, says Jared Holz
Share This

Jared Holz, Mizuho healthcare sector specialist, joins ‘Fast Money’ to discuss Merck’s lawsuit against the federal government over Medicare drug pricing.

Latest Mizuho News

Mizuho Retains “Outstanding” Community Reinvestment Act Ratings

Mizuho Retains “Outstanding” Community Reinvestment Act Ratings

August 10, 2026
Are rising AI costs squeezing Shopify's margins?

Are rising AI costs squeezing Shopify's margins?

August 5, 2026
Mizuho’s Bellinger on Walmart: Gig network of delivery drivers is underappreciated

Mizuho’s Bellinger on Walmart: Gig network of delivery drivers is underappreciated

July 27, 2026

Mizuho news from around the globe

back-to-top-blue